Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest announcement is out from LifeTech Scientific Corporation ( (HK:1302) ).
LifeTech Scientific Corporation announced that its independently developed G-iliac™ Pro iliac artery stent graft system has received official registration approval from China’s National Medical Products Administration, clearing the way for its commercialization in the domestic market. Designed for the endovascular treatment of abdominal aortic aneurysms with associated iliac artery aneurysms or isolated common iliac artery aneurysms, the upgraded device builds on the company’s earlier G-iliac™ iliac branch technology and integrates the flexible SilverFlow™ Pro stent graft to preserve internal iliac artery blood flow while reducing complications linked to traditional embolization. Featuring a low-profile, ergonomically designed delivery system with advanced hydrophilic coating and improved navigation and positioning capabilities, G-iliac™ Pro strengthens LifeTech’s product lineup in full aortic minimally invasive treatment, enhances its competitive position in China’s endovascular reconstruction market, and supports the broader industry shift toward more systematic, standardized and precise management of complex aortic disease.
The most recent analyst rating on (HK:1302) stock is a Hold with a HK$1.50 price target. To see the full list of analyst forecasts on LifeTech Scientific Corporation stock, see the HK:1302 Stock Forecast page.
More about LifeTech Scientific Corporation
LifeTech Scientific Corporation is a medical device company listed in Hong Kong that focuses on minimally invasive endovascular solutions, particularly for aortic and vascular diseases. Its portfolio includes stent graft systems and related technologies aimed at complex aortic and iliac artery reconstructions in the Chinese market and beyond.
Average Trading Volume: 33,516,185
Technical Sentiment Signal: Strong Sell
Current Market Cap: HK$6.95B
For an in-depth examination of 1302 stock, go to TipRanks’ Overview page.